.png)
Respiratory Pathogen Testing Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : December 2020 Pages : 146 Category: Pharma & Healthcare Report Code : HC1213870
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Respiratory Pathogen Testing Market By Type (Bacterial Respiratory Pathogen Testing, Viral Respiratory Pathogen Testing) and Application (Hospitals, Clinics, Diagnostic Laboratories, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Respiratory Pathogen Testing Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Respiratory Pathogen Testing has evolved to better satisfy the needs of healthcare providers,such testing offers high sensitivity, but performing it is expensive, requires the work of highly skilled laboratorians.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Respiratory Pathogen Testing Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Becton, Dickinson and Company
- BoehringerIngelheim GmbH
- GSK
- Abbott Laboratories
- Novartis AG
- Koninklijke Philips N.V.
- Roche
- AstraZeneca
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Respiratory Pathogen Testing Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Bacterial Respiratory Pathogen Testing
o Viral Respiratory Pathogen Testing
· Respiratory Pathogen Testing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Clinics
o Diagnostic Laboratories
o Others
· Respiratory Pathogen Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Becton, Dickinson and Company
o BoehringerIngelheim GmbH
o GSK
o Abbott Laboratories
o Novartis AG
o Koninklijke Philips N.V.
o Roche
o AstraZeneca
· Respiratory Pathogen Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Respiratory Pathogen Testing Market, By Country
o U.S. Respiratory Pathogen Testing Market
o Canada Respiratory Pathogen Testing Market
o Mexico Respiratory Pathogen Testing Market
o Europe
§ Europe Respiratory Pathogen Testing Market, By Country
o UK Respiratory Pathogen Testing Market
o Germany Respiratory Pathogen Testing Market
o France Respiratory Pathogen Testing Market
o Russia Respiratory Pathogen Testing Market
o Italy Respiratory Pathogen Testing Market
o Rest of Europe Respiratory Pathogen Testing Market
o Asia-Pacific
§ Asia-Pacific Respiratory Pathogen Testing Market, By Country
o China Respiratory Pathogen Testing Market
o Japan Respiratory Pathogen Testing Market
o South Korea Respiratory Pathogen Testing Market
o India Respiratory Pathogen Testing Market
o Southeast Asia Respiratory Pathogen Testing Market
o Rest of Asia-Pacific Respiratory Pathogen Testing Market
o South America
§ South America Respiratory Pathogen Testing Market
o Brazil Respiratory Pathogen Testing Market
o Argentina Respiratory Pathogen Testing Market
o Columbia Respiratory Pathogen Testing Market
o Rest of South America Respiratory Pathogen Testing Market
o Middle East and Africa
§ Middle East and Africa Respiratory Pathogen Testing Market
o Saudi Arabia Respiratory Pathogen Testing Market
o UAE Respiratory Pathogen Testing Market
o Egypt Respiratory Pathogen Testing Market
o Nigeria Respiratory Pathogen Testing Market
o South Africa Respiratory Pathogen Testing Market
o TurkeyRespiratory Pathogen Testing Market
o Rest of MEA Respiratory Pathogen Testing Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Respiratory Pathogen Testing Market, By Type
5.1. Introduction
5.2. Global Respiratory Pathogen Testing Revenue and Market Share by Type (2017-2021)
5.2.1. Global Respiratory Pathogen Testing Revenue and Revenue Share by Type (2017-2021)
5.3. Bacterial Respiratory Pathogen Testing
5.3.1. Global Bacterial Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
5.4. Viral Respiratory Pathogen Testing
5.4.1. Global Viral Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
6. Respiratory Pathogen Testing Market, By Applications
6.1. Introduction
6.2. Global Respiratory Pathogen Testing Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Respiratory Pathogen Testing Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
6.4. Clinics
6.4.1. Global Clinics Revenue and Growth Rate (2017-2021)
6.5. Diagnostic Laboratories
6.5.1. Global Diagnostic Laboratories Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Respiratory Pathogen Testing Market, By Region
7.1. Introduction
7.2. Global Respiratory Pathogen Testing Revenue and Market Share by Regions
7.2.1. Global Respiratory Pathogen Testing Revenue by Regions (2017-2021)
7.3. North America Respiratory Pathogen Testing by Countries
7.3.1. North America Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
7.3.2. North America Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Respiratory Pathogen Testing by Countries
7.4.1. Europe Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
7.4.2. Europe Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Respiratory Pathogen Testing by Countries
7.5.1. Asia-Pacific Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Respiratory Pathogen Testing by Countries
7.6.1. South America Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
7.6.2. South America Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Respiratory Pathogen Testing by Countries
7.7.1. Middle East and Africa Respiratory Pathogen Testing Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Becton, Dickinson and Company
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Boehringer Ingelheim GmbH
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. GSK
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Abbott Laboratories
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Novartis AG
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Koninklijke Philips N.V.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Roche
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. AstraZeneca
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Respiratory Pathogen Testing Market Forecast (2022-2027)
9.1. Global Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Respiratory Pathogen Testing Market Forecast by Regions (2022-2027)
9.2.1. North America Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.1.1. United States Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.1.2. Canada Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.1.3. Mexico Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2. Europe Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.1. Germany Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.2. France Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.3. UK Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.4. Russia Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.5. Italy Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3. Asia-Pacific Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.1. China Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.2. Japan Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.3. Korea Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.4. India Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.4. South America Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.4.1. Brazil Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.4.2. Argentina Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.4.3. Columbia Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.4.4. Rest of South America Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5. Middle East and Africa Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.3. Egypt Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.4. Nigeria Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.5. South Africa Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.6. Turkey Respiratory Pathogen Testing Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Respiratory Pathogen Testing Market Forecast (2022-2027)
9.3. Respiratory Pathogen Testing Market Forecast by Type (2022-2027)
9.3.1. Respiratory Pathogen Testing Forecast by Type (2022-2027)
9.3.2. Respiratory Pathogen Testing Market Share Forecast by Type (2022-2027)
9.4. Respiratory Pathogen Testing Market Forecast by Applications (2022-2027)
9.4.1. Respiratory Pathogen Testing Forecast by Applications (2022-2027)
9.4.2. Respiratory Pathogen Testing Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Respiratory Pathogen Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Respiratory Pathogen Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global Bacterial Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure Global Viral Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Table Global Respiratory Pathogen Testing Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Clinics Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Respiratory Pathogen Testing Revenue by Regions (2017-2019)
Figure North America Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure North America Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure North America Respiratory Pathogen Testing by Countries (2017-2019)
Figure North America Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure United States Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Canada Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Mexico Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Europe Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure Europe Respiratory Pathogen Testing by Countries (2017-2019)
Figure Europe Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Germany Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure France Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure UK Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Russia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Italy Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Rest of Europe Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Asia-Pacific Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Respiratory Pathogen Testing by Countries (2017-2019)
Figure Asia-Pacific Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure China Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Japan Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Korea Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure India Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Southeast Asia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure South America Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure South America Respiratory Pathogen Testing by Countries (2017-2019)
Figure South America Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Brazil Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Argentina Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Columbia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Rest of South America Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Middle East and Africa Respiratory Pathogen Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Respiratory Pathogen Testing by Countries (2017-2019)
Figure Middle East and Africa Respiratory Pathogen Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Saudi Arabia Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure United Arab Emirates Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Egypt Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Nigeria Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure South Africa Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Turkey Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Respiratory Pathogen Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Becton, Dickinson and Company Respiratory Pathogen Testing Financial Overview
Table Boehringer Ingelheim GmbH Respiratory Pathogen Testing Financial Overview
Table GSK Respiratory Pathogen Testing Financial Overview
Table Abbott Laboratories Respiratory Pathogen Testing Financial Overview
Table Novartis AG Respiratory Pathogen Testing Financial Overview
Table Koninklijke Philips N.V. Respiratory Pathogen Testing Financial Overview
Table Roche Respiratory Pathogen Testing Financial Overview
Table AstraZeneca Respiratory Pathogen Testing Financial Overview
Figure Global Respiratory Pathogen Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Respiratory Pathogen Testing Market Forecast by Regions (2019-2027)
Figure North America Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure United States Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Canada Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Mexico Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Europe Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Germany Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure France Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure UK Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Russia Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Italy Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Rest of Europe Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Asia-Pacific Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure China Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Japan Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Korea Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure India Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Southeast Asia Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure South America Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Brazil Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Argentina Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Columbia Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Rest of South America Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Middle East and Africa Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Saudi Arabia Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure United Arab Emirates Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Egypt Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Nigeria Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure South Africa Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Turkey Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Respiratory Pathogen Testing Market Forecast (2019-2027)
Figure Global Respiratory Pathogen Testing Forecast by Type (2019-2027)
Figure Global Respiratory Pathogen Testing Market Share Forecast by Type (2019-2027)
Figure Global Respiratory Pathogen Testing Forecast by Type (2019-2027)
Figure Global Respiratory Pathogen Testing Forecast by Applications (2019-2027)
Figure Global Respiratory Pathogen Testing Market Share Forecast by Applications (2019-2027)
Figure Global Respiratory Pathogen Testing Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|